Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$379,936
-$28,672 QoQ
Shares Held
40,722
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#215
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $2,219,060 across 4 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (17.1% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $379,936 | 40,722 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $408,608 | 40,820 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $418,937 | 41,438 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $381,143 | 42,491 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $498,205 | 48,043 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $452,410 | 43,966 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $425,340 | 44,585 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $474,449 | 44,844 | Shares | Defined | 2024-11-26 | |
| 2024-06-30 | $358,930 | 43,454 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $319,334 | 37,613 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $234,390 | 28,480 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $245,984 | 29,530 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $954,741 | 113,931 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $808,968 | 99,382 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $794,064 | 99,258 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $540,274 | 88,715 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||